Cord blood trial aims to beat long COVID fatigue
Symptom relief
Not yet recruiting
This phase 3 study tests if an infusion of human umbilical cord blood (REGENECYTE) can reduce fatigue in people with Long COVID. About 60 adults with post-COVID condition will receive either the cord blood infusion or a placebo. The main goal is to see if fatigue improves, while …
Phase: PHASE3 • Sponsor: StemCyte, Inc. • Aim: Symptom relief
Last updated Jun 15, 2026 19:03 UTC